Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Formulation and Delivery Technologies for mRNA Vaccines
Chunxi Zeng, Chengxiang Zhang, Patrick Walker, et al.
Current topics in microbiology and immunology (2020), pp. 71-110
Open Access | Times Cited: 179

Showing 1-25 of 179 citing articles:

Lipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Róbert Langer, et al.
Nature Reviews Materials (2021) Vol. 6, Iss. 12, pp. 1078-1094
Open Access | Times Cited: 2197
mRNA vaccine for cancer immunotherapy
Lei Miao, Yu Zhang, Leaf Huang
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 693
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu, Minyang Fu, Manni Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 473
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 406
Self-assembled mRNA vaccines
Jeonghwan Kim, Yulia Eygeris, Mohit Gupta, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 83-112
Open Access | Times Cited: 379
mRNA vaccines manufacturing: Challenges and bottlenecks
Sara Sousa Rosa, D.M.F. Prazeres, Ana M. Azevedo, et al.
Vaccine (2021) Vol. 39, Iss. 16, pp. 2190-2200
Open Access | Times Cited: 364
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 343
Clinical advances and ongoing trials of mRNA vaccines for cancer treatment
Cathrine Lund Lorentzen, John B.A.G. Haanen, Özcan Met, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 10, pp. e450-e458
Open Access | Times Cited: 327
mRNA therapeutics in cancer immunotherapy
Jan D. Beck, Daniel Reidenbach, Nadja Salomon, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 274
mRNA vaccines for COVID-19: what, why and how
Jung Woo Park, Philip N.P. Lagniton, Yu Liu, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1446-1460
Open Access | Times Cited: 271
Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery
William Ho, Mingzhu Gao, Fengqiao Li, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 8
Open Access | Times Cited: 206
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
Ruklanthi de Alwis, Esther S. Gan, Shiwei Chen, et al.
Molecular Therapy (2021) Vol. 29, Iss. 6, pp. 1970-1983
Open Access | Times Cited: 153
Delivery Strategies for mRNA Vaccines
Sivakumar Ramachandran, Soumya Ranjan Satapathy, Tathagata Dutta
Pharmaceutical Medicine (2022) Vol. 36, Iss. 1, pp. 11-20
Open Access | Times Cited: 129
mRNA cancer vaccines: Advances, trends and challenges
Qing He, Hua Gao, Tan De-jiang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 2969-2989
Open Access | Times Cited: 96
An Overview of Nanoparticle Protein Corona Literature
Mohammad Javad Hajipour, Reihaneh Safavi‐Sohi, Shahriar Sharifi, et al.
Small (2023) Vol. 19, Iss. 36
Open Access | Times Cited: 65
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
Feng Zhou, Lujia Huang, Shiqin Li, et al.
Exploration (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 50
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Muhammad Moazzam, Jun Zhang, Abid Hussain, et al.
Molecular Therapy (2024) Vol. 32, Iss. 2, pp. 284-312
Closed Access | Times Cited: 46
Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects
Zhe Cheng, Huichao Huang, Mingru Yin, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 2
mRNA-Based Vaccines
Frank Kowalzik, Daniel Schreiner, Christian Jensen, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 390-390
Open Access | Times Cited: 93
Advances in gene-based vaccine platforms to address the COVID-19 pandemic
Deborah Pushparajah, Salma Jimenez, Shirley Wong, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 113-141
Open Access | Times Cited: 92
From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 90
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2150-2150
Open Access | Times Cited: 64
Perspectives on RNA Vaccine Candidates for COVID-19
Pobitra Borah, Pran Kishore Deb, Nizar A. Al‐Shar’i, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 56
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases
Ting Le, Chao Sun, Jitao Chang, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 401-401
Open Access | Times Cited: 56
Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects
Adebayo J. Molehin, Donald P. McManus, Hong You
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2255-2255
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top